In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Using an AI coding assistant to migrate an application from one programming language to another wasn’t as easy as it looked. Here are three takeaways.

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

First, you spend a small fortune just to buy the unit and install it. Then comes the real nightmare: maintenance and repairs that are outrageously expensive, to the point where it feels like a scam.